ERBB2 and breast carcinoma: The clinical classification of breast cancer is based on the presence of transmembrane receptors, namely estrogen and progesterone, along with the amplification or overexpression of the human epidermal growth factor receptor 2 (HER2) protein/oncogene1,2.